204 related articles for article (PubMed ID: 23620811)
1. Chronic treatment with the AMP-kinase activator AICAR increases glycogen storage and fatty acid oxidation in skeletal muscles but does not reduce hyperglucagonemia and hyperglycemia in insulin deficient rats.
Vitzel KF; Bikopoulos G; Hung S; Pistor KE; Patterson JD; Curi R; Ceddia RB
PLoS One; 2013; 8(4):e62190. PubMed ID: 23620811
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of insulin-stimulated glycogen synthesis by 5-aminoimidasole-4-carboxamide-1-beta-d-ribofuranoside-induced adenosine 5'-monophosphate-activated protein kinase activation: interactions with Akt, glycogen synthase kinase 3-3alpha/beta, and glycogen synthase in isolated rat soleus muscle.
Fediuc S; Gaidhu MP; Ceddia RB
Endocrinology; 2006 Nov; 147(11):5170-7. PubMed ID: 16873531
[TBL] [Abstract][Full Text] [Related]
3. The alpha2-5'AMP-activated protein kinase is a site 2 glycogen synthase kinase in skeletal muscle and is responsive to glucose loading.
Jørgensen SB; Nielsen JN; Birk JB; Olsen GS; Viollet B; Andreelli F; Schjerling P; Vaulont S; Hardie DG; Hansen BF; Richter EA; Wojtaszewski JF
Diabetes; 2004 Dec; 53(12):3074-81. PubMed ID: 15561936
[TBL] [Abstract][Full Text] [Related]
4. Prior treatment with the AMPK activator AICAR induces subsequently enhanced glucose uptake in isolated skeletal muscles from 24-month-old rats.
Oki K; Arias EB; Kanzaki M; Cartee GD
Appl Physiol Nutr Metab; 2018 Aug; 43(8):795-805. PubMed ID: 29518344
[TBL] [Abstract][Full Text] [Related]
5. Loss of the anorexic response to systemic 5-aminoimidazole-4-carboxamide-1-β-D-ribofuranoside administration despite reducing hypothalamic AMP-activated protein kinase phosphorylation in insulin-deficient rats.
Vitzel KF; Bikopoulos G; Hung S; Curi R; Ceddia RB
PLoS One; 2013; 8(8):e71944. PubMed ID: 23967267
[TBL] [Abstract][Full Text] [Related]
6. Effect of 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside infusion on in vivo glucose and lipid metabolism in lean and obese Zucker rats.
Bergeron R; Previs SF; Cline GW; Perret P; Russell RR; Young LH; Shulman GI
Diabetes; 2001 May; 50(5):1076-82. PubMed ID: 11334411
[TBL] [Abstract][Full Text] [Related]
7. A null mutation in skeletal muscle FAT/CD36 reveals its essential role in insulin- and AICAR-stimulated fatty acid metabolism.
Bonen A; Han XX; Habets DD; Febbraio M; Glatz JF; Luiken JJ
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1740-9. PubMed ID: 17264223
[TBL] [Abstract][Full Text] [Related]
8. Short-term AMP-regulated protein kinase activation enhances insulin-sensitive fatty acid uptake and increases the effects of insulin on fatty acid oxidation in L6 muscle cells.
Kelly KR; Abbott MJ; Turcotte LP
Exp Biol Med (Maywood); 2010 Apr; 235(4):514-21. PubMed ID: 20407084
[TBL] [Abstract][Full Text] [Related]
9. AMP kinase activation ameliorates insulin resistance induced by free fatty acids in rat skeletal muscle.
Olsen GS; Hansen BF
Am J Physiol Endocrinol Metab; 2002 Nov; 283(5):E965-70. PubMed ID: 12376323
[TBL] [Abstract][Full Text] [Related]
10. AMP kinase activation with AICAR further increases fatty acid oxidation and blunts triacylglycerol hydrolysis in contracting rat soleus muscle.
Smith AC; Bruce CR; Dyck DJ
J Physiol; 2005 Jun; 565(Pt 2):547-53. PubMed ID: 15774529
[TBL] [Abstract][Full Text] [Related]
11. Insulin stimulation of glucose uptake fails to decrease palmitate oxidation in muscle if AMPK is activated.
Winder WW; Holmes BF
J Appl Physiol (1985); 2000 Dec; 89(6):2430-7. PubMed ID: 11090599
[TBL] [Abstract][Full Text] [Related]
12. Impact of in vivo fatty acid oxidation blockade on glucose turnover and muscle glucose metabolism during low-dose AICAR infusion.
Christopher M; Rantzau C; Chen ZP; Snow R; Kemp B; Alford FP
Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1131-40. PubMed ID: 16772328
[TBL] [Abstract][Full Text] [Related]
13. AMP kinase activation with AICAR simultaneously increases fatty acid and glucose oxidation in resting rat soleus muscle.
Smith AC; Bruce CR; Dyck DJ
J Physiol; 2005 Jun; 565(Pt 2):537-46. PubMed ID: 15774530
[TBL] [Abstract][Full Text] [Related]
14. Restoring AS160 phosphorylation rescues skeletal muscle insulin resistance and fatty acid oxidation while not reducing intramuscular lipids.
Alkhateeb H; Chabowski A; Glatz JF; Gurd B; Luiken JJ; Bonen A
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1056-66. PubMed ID: 19724017
[TBL] [Abstract][Full Text] [Related]
15. AMP-activated protein kinase activation by AICAR increases both muscle fatty acid and glucose uptake in white muscle of insulin-resistant rats in vivo.
Iglesias MA; Furler SM; Cooney GJ; Kraegen EW; Ye JM
Diabetes; 2004 Jul; 53(7):1649-54. PubMed ID: 15220186
[TBL] [Abstract][Full Text] [Related]
16. Chronic treatment with 5-aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside increases insulin-stimulated glucose uptake and GLUT4 translocation in rat skeletal muscles in a fiber type-specific manner.
Buhl ES; Jessen N; Schmitz O; Pedersen SB; Pedersen O; Holman GD; Lund S
Diabetes; 2001 Jan; 50(1):12-7. PubMed ID: 11147776
[TBL] [Abstract][Full Text] [Related]
17. Effect of AICAR treatment on glycogen metabolism in skeletal muscle.
Aschenbach WG; Hirshman MF; Fujii N; Sakamoto K; Howlett KF; Goodyear LJ
Diabetes; 2002 Mar; 51(3):567-73. PubMed ID: 11872652
[TBL] [Abstract][Full Text] [Related]
18. Effects of AICAR and exercise on insulin-stimulated glucose uptake, signaling, and GLUT-4 content in rat muscles.
Jessen N; Pold R; Buhl ES; Jensen LS; Schmitz O; Lund S
J Appl Physiol (1985); 2003 Apr; 94(4):1373-9. PubMed ID: 12496137
[TBL] [Abstract][Full Text] [Related]
19. 5-Aminoimidazole-4-carboxamide-1-beta-D-ribofuranoside-induced AMP-activated protein kinase phosphorylation inhibits basal and insulin-stimulated glucose uptake, lipid synthesis, and fatty acid oxidation in isolated rat adipocytes.
Gaidhu MP; Fediuc S; Ceddia RB
J Biol Chem; 2006 Sep; 281(36):25956-64. PubMed ID: 16816404
[TBL] [Abstract][Full Text] [Related]
20. Regulation of fatty acid oxidation and glucose metabolism in rat soleus muscle: effects of AICAR.
Kaushik VK; Young ME; Dean DJ; Kurowski TG; Saha AK; Ruderman NB
Am J Physiol Endocrinol Metab; 2001 Aug; 281(2):E335-40. PubMed ID: 11440910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
